Showing all 11 results
Buy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) Online
$305.35(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease
MANUFACTURER: AstraZeneca Pharmaceuticals LP
USAGE: Oral
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Breztri Aerosphere is a pharmaceutical medication that is primarily used for the treatment of chronic obstructive pulmonary disease (COPD). This medication is designed to provide relief and management of the symptoms associated with COPD, which includes chronic bronchitis and emphysema.
$305.35
Buy Clenbuterol Harasawa Online
$102.85(0 Reviews)
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Harasawa
USAGE: Oral
MEDICINE APPROVED BY:
Pharmaceuticals and Medical Devices Agency (PMDA)
Clenbuterol, a medication employed in the management of individuals afflicted with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence, has diverse applications in the medical field.
Notably, physicians occasionally opt for Clenbuterol's off-label use in the treatment of patients grappling with ALS (Amyotrophic Lateral Sclerosis).
It's worth mentioning that Clenbuterol was previously recognized by its brand name, TONIL (clenbuterol).
$102.85
Buy Kalydeco (ivacaftor) Online
From $7,241.59(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Kalydeco (ivacaftor) is a medication prescribed for individuals with cystic fibrosis (CF) who are 4 months of age and older and possess at least one CF gene mutation that responds to Kalydeco treatment.
From $7,241.59
Buy Lucaftor (lumacaftor/ivacaftor) Online
$3,054.56(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Gador SA
USAGE: Oral
MEDICINE APPROVED BY:
ANMAT (ARG)
Lucaftor is not a standalone medication but a combination therapy that consists of two active ingredients: lumacaftor and ivacaftor. This combination medication is used for the treatment of a specific genetic disorder known as cystic fibrosis (CF). It is designed to address the underlying cause of CF in individuals who have a specific mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene.
$3,054.56
Buy Orkambi (lumacaftor/ivacaftor) Online
From $10,806.14(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Therapeutic Goods Administration (TGA)
This medication is designed to address the underlying cause of CF in individuals who have two copies of the F508del mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which is a common genetic mutation associated with CF.
From $10,806.14
Buy Symdeko (tezacaftor / ivacaftor) Online
$39,418.95(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
, Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.
$39,418.95
Buy Symkevi (tezacaftor/ivacaftor) Online
$5,729.85(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.
$5,729.85
Buy Tezspire (tezepelumab-ekko) Online
$6,696.25(0 Reviews)
DISEASE INDICATIONS: Asthma
MANUFACTURER: Amgen / AstraZeneca AB
USAGE: Subcutaneous
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.
$6,696.25
Buy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Online
$755.34(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma
MANUFACTURER: GlaxoSmithKline
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
It is used for the management of chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by breathing difficulties, coughing, and wheezing. This medication is designed to provide comprehensive treatment for COPD by addressing various aspects of the disease.
$755.34
Buy Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Online
From $39,106.10(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals Incorporated
USAGE: Oral
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Trikafta is designed to address the underlying genetic mutations in individuals with CF and has been shown to significantly improve lung function and overall health in many patients.
From $39,106.10
Buy Yupelri (revefenacin) Online
(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease
MANUFACTURER: Theravance Biopharma
USAGE: Oral
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Yupelri is a pharmaceutical medication used to treat chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by difficulty breathing, coughing, and wheezing.
